【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 7
2 Introduction 8
2.1 Artificial Pancreas Overview 8
3 Products under Development 9
3.1 Artificial Pancreas – Pipeline Products by Stage of Development 9
3.2 Artificial Pancreas – Pipeline Products by Territory 10
3.3 Artificial Pancreas – Pipeline Products by Regulatory Path 11
3.4 Artificial Pancreas – Pipeline Products by Estimated Approval Date 12
3.5 Artificial Pancreas – Ongoing Clinical Trials 13
4 Artificial Pancreas – Pipeline Products under Development by Companies 14
4.1 Artificial Pancreas Companies – Pipeline Products by Stage of Development 14
4.2 Artificial Pancreas – Pipeline Products by Stage of Development 16
5 Artificial Pancreas Companies and Product Overview 18
5.1 Advanced Biosensors-Ohio, Llc Company Overview 18
5.1.1 Advanced Biosensors-Ohio, Llc Pipeline Products & Ongoing Clinical Trials Overview 18
5.2 Animas Corporation Company Overview 19
5.2.1 Animas Corporation Pipeline Products & Ongoing Clinical Trials Overview 19
5.3 Beta-O2 Technologies Ltd. Company Overview 21
5.3.1 Beta-O2 Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 Bigfoot Biomedical, Inc. Company Overview 25
5.4.1 Bigfoot Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.5 BioTex, Inc. Company Overview 26
5.5.1 BioTex, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
5.6 Boston University Company Overview 27
5.6.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 Cerco Medical Company Overview 28
5.7.1 Cerco Medical Pipeline Products & Ongoing Clinical Trials Overview 28
5.8 Converge Biotech, Inc. Company Overview 29
5.8.1 Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
5.9 Covalor Medical, LLC Company Overview 30
5.9.1 Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 30
5.10 De Montfort University Company Overview 31
5.10.1 De Montfort University Pipeline Products & Ongoing Clinical Trials Overview 31
5.11 Defymed Company Overview 32
5.11.1 Defymed Pipeline Products & Ongoing Clinical Trials Overview 32
5.12 Diabeloop Company Overview 33
5.12.1 Diabeloop Pipeline Products & Ongoing Clinical Trials Overview 33
5.13 Dose Safety Inc. Company Overview 34
5.13.1 Dose Safety Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
5.14 Imperial College London Company Overview 35
5.14.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 35
5.15 Inreda Diabetic BV Company Overview 39
5.15.1 Inreda Diabetic BV Pipeline Products & Ongoing Clinical Trials Overview 39
5.16 Kencak LLC Company Overview 40
5.16.1 Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview 40
5.17 Medtronic plc Company Overview 41
5.17.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 41
5.18 Miromatrix Medical Inc. Company Overview 48
5.18.1 Miromatrix Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.19 Pacific Diabetes Technologies, Inc. Company Overview 49
5.19.1 Pacific Diabetes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.20 Pancreum, LLC Company Overview 50
5.20.1 Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview 50
5.21 PharmaCyte Biotech, Inc. Company Overview 51
5.21.1 PharmaCyte Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.22 Rensselaer Polytechnic Institute Company Overview 53
5.22.1 Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 53
5.23 Schneider Children’s Medical Center of Israel Company Overview 55
5.23.1 Schneider Children’s Medical Center of Israel Pipeline Products & Ongoing Clinical Trials Overview 55
5.24 TecMed, Inc. Company Overview 57
5.24.1 TecMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
5.25 The University of Newcastle Company Overview 58
5.25.1 The University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview 58
5.26 Ultradian Diagnostics LLC Company Overview 59
5.26.1 Ultradian Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 59
5.27 Universidad Autonoma de Madrid Company Overview 60
5.27.1 Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview 60
5.28 Universitat Politecnica de Valencia Company Overview 61
5.28.1 Universitat Politecnica de Valencia Pipeline Products & Ongoing Clinical Trials Overview 61
5.29 University of California, San Francisco Company Overview 62
5.29.1 University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 62
5.30 University of California, Santa Barbara Company Overview 63
5.30.1 University of California, Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 63
5.31 University of Cambridge Company Overview 65
5.31.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 65
5.32 University of Florida Company Overview 66
5.32.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 66
5.33 University of Virginia Company Overview 67
5.33.1 University of Virginia Pipeline Products & Ongoing Clinical Trials Overview 67
5.34 ViaCyte, Inc. Company Overview 71
5.34.1 ViaCyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
5.35 XERIS Pharmaceuticals, Inc. Company Overview 75
5.35.1 XERIS Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
6 Artificial Pancreas – Recent Developments 76
7 Appendix 81
7.1 Methodology 81
7.2 About GlobalData 83
7.3 Contact Us 83
7.4 Disclaimer 83
【レポート販売概要】
■ タイトル：世界における人工膵臓の製品パイプライン動向2015■ 英文：Artificial Pancreas - Pipeline Review, 2015
■ 発行日：2015年6月10日
■ 調査会社：GlobalData
■ 商品コード：GDME0033EPD
■ 調査対象地域：グローバル
- Inherited Orphan Blood Disorders Therapeutics Market to 2019 – Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet NeedInherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need Summary GBI Research, the leading business intelligence provider, has released its latest research, “Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need”. The report provides insights in …
- セラミックコーティングの世界市場2016-2020：酸化物系セラミックコーティング、炭化ケイ素系セラミックコーティング、窒化系セラミックコーティングAbout Ceramic Coatings Ceramic coatings resist wear, tear, erosion, and high temperature on a wide range of application areas, such as automotive, aerospace and defense, energy, and healthcare. The automotive industry is the major end-user segment for ceramic coatings. Automobile headers, exhaust pipes, and turbocharger parts are usually ceramic coated to protect them from chemicals, heat, and exh …
- 血液処理装置および消耗品の世界市場2016-2020About Blood Processing Devices and Consumables Globally, blood processing devices and consumables are getting attention from various healthcare institutions and other medical facilities where blood storage and transfusion have been part of improved patient treatment. Cord blood processing is gaining critical importance for stem cell research as well as blood disease therapy and the limited availab …
- 自己導尿カテーテルの世界市場：断続的カテーテル、外部カテーテルThe global urinary self-catheters market was valued at $1,722 million in 2018, and is projected to reach $2,387 million by 2026, registering a CAGR of 4.1% from 2019 to 2026. A urinary catheter is a hollow, partially flexible tube, which is used to drain the urine when an individual is unable to do it naturally. These catheters consist of a drainage bag that assists to collect a urine. They are co …
- 高齢者・障害者補助デバイスの世界市場：聴覚補助具、移動・歩行補助デバイス、視覚補助具、医療用家具及び浴室安全機器About Elderly and Disabled Assistive Elderly and disabled assistive devices enable the elderly and disabled population in carrying out their everyday activities such as movement, hearing and reading with ease. The devices are primarily designed for the elderly and disabled population to live more independently with a good quality of life. The devices include both simple and complex products in des …
- 血管閉鎖デバイスの世界市場予測（～2022年）：コラーゲンプラグ、密閉剤/ゲル、クリップ、縫合装置The global vascular closure devices market is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%. The major drivers for the market include a large number of approvals for vascular closure devices, increasing focus of market players on large-bore vascular closure devices, the high prevalence of cardiovascular diseases, and high prevalence of obesity. On th …
- HPV検査の世界市場2016-2020About HPV Testing According to Centers for Disease Control and Prevention (CDC), human papillomavirus (HPV) refers to a group of more than 100 related viruses that commonly cause infections and do not have any symptoms. Among these, more than 40 types of HPVs cause highly contagious diseases that are transmitted through direct sexual contact, infecting both male and female genitals. The other type …
- 乗用車用GPF（ガソリン・パティキュレート・フィルタ）の世界市場2016-2020About GPFs GPFs are used for controlling the emission levels of particulate matter number of direct fuel injected gasoline cars. They are fitted with the exhaust system of the vehicle. The filter’s substrate wall traps and collects the particulate matter from the engine exhaust gases before releasing, reducing the particulate emission levels. Technavio’s analysts forecast the global gasoline parti …
- 世界のホットドリンク市場動向（2014年4月）：ニュース・イベントSynopsis Using this report, marketers will effectively gain an insight into the latest happenings in the global hot drinks market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global hot drinks market on a monthly basis. Scope The report provides a review of the latest news and key events in the global …
- キレート剤の世界市場2016-2020About the Chelating Agents Market Chelating agents, also called chelants, sequestering agents, or complexing agents, form stable complexes after mixing with metal ions. These compounds achieve this by synchronizing with the metal ions of at least two sites, inactivating and solubilizing the metal ions that would otherwise damage the system on which they have been used. Chelating agents are primari …
- Equal Energy Ltd：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Equal Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Equal Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key o …
- 腹水(Ascites)：世界の治験レビュー（2015年上半期版）Ascites Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Ascites Global Clinical Trials Review, H1, 2015" provides data on the Ascites clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ascites. It includes an overview of the trial numbers and their recruitment status as per the site of trial conductio …
- 世界におけるGPS/GNSS市場2013-2023（SWOT分析）Synopsis This report provides readers with an exhaustive analysis of industry characteristics, determining the strengths, weaknesses, opportunities and threats faced by the Military GPS/GNSS market. Summary This SWOT analysis of Military GPS/GNSS market is a crucial resource for industry executives and anyone looking to gain a better understanding of the market. SDI's "The Global Military GPS/GNSS …
- サーバリックス（Cervarix/ヒトパピローマウイルスワクチン）：市場予測と分析（～2022）Cervarix (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. The global HPV vaccines market is now well established, yet vaccine coverage rates amongst the traditional target population of adolescent girls remain persistently low. Initially HPV vaccin …
- エチレンオキシド(EO)の世界市場予測Ethylene Oxide 2013 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about ethylene oxide market in the all-in-one report issued in a logical and easily accessible format. In addition to the analytical …
